WLJ van Putten

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Hein Putter, IM Jürgenliemk-Schulz, JJ Jobsen et al. · The Lancet · 2010 · 1.1K citations

Medicine, Oncology, Radiation Oncology +14

A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group

GJ Ossenkoppele, Bronno van der Holt, Geg Verhoef et al. · Leukemia · 1999 · 29 citations

Medicine, Hematology, Oncology +14

The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients

J.G.M. Klijn, Martina Schmitt, WLJ van Putten et al. · European Journal of Cancer · 1993 · 21 citations

Medicine, Biostatistics, Oncology +12

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients

S Romain, Olivier Chinot, J.G.M. Klijn et al. · British Journal of Cancer · 1994 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +12